Related Experiment Video
Updated: Jul 28, 2026
10:26
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
[Anticoagulation in patients with venous thromboembolism]
1Abteilung für Hämatologie, Medizinische Klinik, Kantonsspital Luzern.
Therapeutische Umschau. Revue Therapeutique
|March 18, 2003
Summary
Venous thromboembolism, encompassing deep vein thrombosis and pulmonary embolism, is effectively managed with anticoagulation. Low molecular weight heparins offer advantages for outpatient treatment of deep vein thrombosis.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Vascular Surgery
Background:
- Deep venous thrombosis (DVT) and pulmonary embolism (PE) are recognized as manifestations of venous thromboembolism (VTE).
- VTE shares similar pathogenesis, treatment strategies, and prognostic outcomes, leading to its unified classification in recent literature.
Purpose of the Study:
- To review the current understanding and therapeutic approaches for venous thromboembolism.
- To highlight the role of anticoagulation, particularly low molecular weight heparins (LMWHs), in VTE management.
- To discuss the feasibility and limitations of outpatient VTE treatment.
Main Methods:
- Review of current literature on venous thromboembolism management.
- Emphasis on anticoagulation therapy, including heparin and coumarin derivatives.
- Discussion of adjunctive therapies and preventative measures.
Main Results:
- Low molecular weight heparins are the preferred initial therapy due to pharmacokinetic advantages and ease of administration.
- LMWHs allow for weight-adapted dosing and daily subcutaneous injections, minimizing the need for laboratory monitoring.
- Outpatient treatment is feasible for DVT, while PE outpatient management requires further investigation.
- Concurrent initiation of coumarin therapy with heparin minimizes heparin-induced thrombocytopenia.
- An INR of 2.0 to 3.0 indicates effective coumarin therapy for VTE.
Conclusions:
- Venous thromboembolism management relies on anticoagulation, with LMWHs as a cornerstone therapy.
- Outpatient treatment protocols are evolving, particularly for DVT.
- Compression stockings can mitigate the risk of post-thrombotic syndrome following DVT.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...